ResMed Inc (ASX: RMD) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

ResMed Inc Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $42.90 billion
P/E Ratio 31.98
Dividend Yield 0.97%
Shares Outstanding 1.47 billion
Earnings per share 0.604
Dividend per share 0.29
Year To Date Return 14.87%
Earnings Yield 3.13%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • ResMed Inc (ASX: RMD)
    Latest News

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    1 ASX stock to consider buying that could be the next ResMed

    There are obviously no guarantees in the share market. But if you're willing to take on some risk, the rewards…

    Read more »

    A man wearing a white coat and glasses is wide-mouthed in surprise.
    Healthcare Shares

    GLP-1 obesity medicines do the opposite of what ResMed stock investors feared

    Internal research from ResMed provides some surprising news for investors on the impact of GLP-1s.

    Read more »

    A young well-dressed couple at a luxury resort celebrate successful life choices.
    Growth Shares

    A once-in-a-decade chance to get rich buying ASX growth stocks?

    Analysts think these shares are buys. Could they be the key to growing your wealth?

    Read more »

    Fund portfolio manager Hamish Tadgell
    Investing Strategies

    2 ASX 200 shares to buy in the most 'interesting' sector right now

    One had an excellent 2023 while the other suffered from market perception. Both are winners, according to SG Hiscock's Hamish…

    Read more »

    A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
    Broker Notes

    Bell Potter names the best ASX shares to buy in March

    The broker thinks investors should be snapping up their shares.

    Read more »

    Scientist looking at a laptop thinking about the share price performance.
    Share Market News

    Up 37% from their low: Can ResMed shares keep rising?

    Analysts have given their verdict on the ResMed rebound.

    Read more »

    Three people in a corporate office pour over a tablet, ready to invest.
    Cheap Shares

    3 reliable ASX shares you can buy at a discount

    Of course, all investors want to buy quality stocks for a cheap price. But if everyone could do it, we'd…

    Read more »

    a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was a happy session for the ASX today, with almost all sectors rising.

    Read more »

    A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
    Broker Notes

    Morgans names more of the best ASX 200 shares to buy in March

    These ASX 200 shares are highly rated by analysts at Morgans in March.

    Read more »

    Happy couple enjoying ice cream in retirement.
    Share Fallers

    2 classic ASX 200 shares you can buy for cheap now to hold for years

    Experts reckon these well-known stocks are in a temporary dip that shrewd investors could take advantage of.

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Broker Notes

    These ASX 200 shares could rise 20% to 50%

    Big returns could be on the cards according to analysts.

    Read more »

    A little boy holds his fingers to his head posing as a bull.
    Blue Chip Shares

    Here are 2 high-quality ASX 200 blue chip shares that analysts are bullish on

    These blue chips have been given a big thumbs up.

    Read more »

    Frequently Asked Questions

    Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.

    Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    07 Feb 2024 $0.0517 0.00% Interim 14 Mar 2024
    08 Nov 2023 $0.0528 0.00% Interim 14 Dec 2023
    16 Aug 2023 $0.0524 0.00% Final 21 Sep 2023
    10 May 2023 $0.0460 0.00% Interim 15 Jun 2023
    08 Feb 2023 $0.0444 0.00% Interim 16 Mar 2023
    09 Nov 2022 $0.0466 0.00% Interim 15 Dec 2022
    17 Aug 2022 $0.0445 0.00% Final 22 Sep 2022
    11 May 2022 $0.0429 0.00% Interim 16 Jun 2022
    09 Feb 2022 $0.0410 0.00% Interim 17 Mar 2022
    10 Nov 2021 $0.0403 0.00% Interim 16 Dec 2021
    18 Aug 2021 $0.0412 0.00% Final 23 Sep 2021
    12 May 2021 $0.0354 0.00% Interim 17 Jun 2021
    10 Feb 2021 $0.0352 0.00% Interim 18 Mar 2021
    11 Nov 2020 $0.0378 0.00% Interim 17 Dec 2020
    19 Aug 2020 $0.0379 0.00% Final 24 Sep 2020
    13 May 2020 $0.0423 0.00% Interim 18 Jun 2020
    12 Feb 2020 $0.0406 0.00% Interim 19 Mar 2020
    06 Nov 2019 $0.0396 0.00% Interim 12 Dec 2019
    14 Aug 2019 $0.0403 0.00% Final 19 Sep 2019
    08 May 2019 $0.0371 0.00% Interim 13 Jun 2019
    06 Feb 2019 $0.0365 0.00% Interim 14 Mar 2019
    07 Nov 2018 $0.0356 0.00% Interim 13 Dec 2018
    15 Aug 2018 $0.0357 0.00% Final 20 Sep 2018
    09 May 2018 $0.0326 0.00% Interim 14 Jun 2018
    07 Feb 2018 $0.0315 0.00% Interim 15 Mar 2018
    08 Nov 2017 $0.0320 0.00% Interim 14 Dec 2017
    16 Aug 2017 $0.0308 0.00% Final 21 Sep 2017
    10 May 2017 $0.0313 0.00% Interim 15 Jun 2017
    08 Feb 2017 $0.0303 0.00% Interim 16 Mar 2017
    09 Nov 2016 $0.0303 0.00% Interim 15 Dec 2016
    17 Aug 2016 $0.0300 0.00% Final 22 Sep 2016
    18 May 2016 $0.0291 0.00% Interim 16 Jun 2016
    09 Feb 2016 $0.0295 0.00% Interim 17 Mar 2016
    17 Nov 2015 $0.0292 0.00% Interim 17 Dec 2015

    RMD ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About ResMed Inc

    ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.

    It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.

    RMD Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    18 Mar 2024 $28.88 $-0.27 -0.93% 1,242,646 $29.01 $29.07 $28.67
    15 Mar 2024 $29.15 $0.17 0.59% 10,206,374 $29.00 $29.32 $28.90
    14 Mar 2024 $28.98 $-0.10 -0.34% 1,390,125 $29.00 $29.15 $28.89
    13 Mar 2024 $29.08 $0.56 1.96% 2,276,306 $29.25 $29.40 $29.04
    12 Mar 2024 $28.52 $0.62 2.22% 1,936,464 $28.56 $28.70 $28.32
    11 Mar 2024 $27.90 $-1.07 -3.69% 2,128,114 $28.50 $28.50 $27.85
    08 Mar 2024 $28.97 $0.15 0.52% 2,507,097 $29.17 $29.24 $28.92
    07 Mar 2024 $28.82 $1.49 5.45% 4,700,481 $28.05 $28.92 $28.01
    06 Mar 2024 $27.33 $-0.48 -1.73% 2,298,924 $27.40 $27.44 $27.25
    05 Mar 2024 $27.81 $0.86 3.19% 1,935,643 $27.80 $27.94 $27.66
    04 Mar 2024 $26.95 $0.23 0.86% 1,771,245 $26.72 $27.08 $26.66
    01 Mar 2024 $26.72 $0.06 0.23% 1,507,430 $26.65 $26.93 $26.64
    29 Feb 2024 $26.66 $-1.27 -4.55% 3,977,960 $27.00 $27.00 $26.66
    28 Feb 2024 $27.93 $0.08 0.29% 1,379,898 $27.67 $28.04 $27.65
    27 Feb 2024 $27.85 $-0.40 -1.42% 1,109,084 $28.06 $28.16 $27.84
    26 Feb 2024 $28.25 $0.26 0.93% 1,100,549 $28.10 $28.42 $28.04
    23 Feb 2024 $27.99 $0.44 1.60% 1,684,276 $27.79 $28.05 $27.77
    22 Feb 2024 $27.55 $0.03 0.11% 1,165,551 $27.60 $27.67 $27.48
    21 Feb 2024 $27.52 $0.09 0.33% 1,143,513 $27.70 $27.76 $27.31
    20 Feb 2024 $27.43 $-0.10 -0.36% 1,037,664 $27.53 $27.80 $27.42

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Peter Craig Farrell Non-Executive DirectorNon-Executive Chairman Jul 2002
    No profile reported in Annual Report.
    Mr Ronald R Taylor Non-Executive Director Jan 2005
    Mr Taylor is a director of Actavis, Inc. and Red Lion Hotels Corp. From 2002 until his appointment to the ResMed board in 2005, he served as chairman of the ResMed Foundation. In 1987, Mr. Taylor founded Pyxis Corporation where he served as chairman, president, and chief executive officer until its purchase by Cardinal Health, Inc., in 1996.
    Mr Richard Sulpizio Non-Executive Director Aug 2005
    Mr Sulpizio has served as president and chief executive officer of Qualcomm Enterprise Services. He currently serves as a senior advisor to Qualcomm Enterprise Services. Mr Sulpizio held various positions with Qualcomm during his 20-year tenure there, including president and chief operating officer. He served as a member of Qualcomm's board of directors from 2000 until 2007.
    Mr Michael J Farrell Chief Executive OfficerExecutive Director Mar 2013
    Mr Farrell was foundation director of Biomedical Engineering at the University of New South Wales where he currently serves as a visiting professor and as chairman of the UNSW Centre for Innovation and Entrepreneurship. Since 2005, Dr Farrell has been a director of NuVasive, Inc. He also serves as the non-executive chair of QRxPharma.
    Ms Carol Burt Non-Executive Director Aug 2014
    No profile reported in Annual Report.
    Ms Karen Ruth Drexler Non-Executive Director Nov 2017
    No profile reported in Annual Report.
    Mr Jan De Witte Non-Executive Director May 2019
    Mr De Witte is the chief executive officer and member of the board of directors of Barco NV.
    Ms Harjit Gill Non-Executive Director Nov 2018
    No profile reported in Annual Report.
    Mr John Hernandez Non-Executive Director Nov 2021
    No profile reported in Annual Report.
    Mr Desney Tan Non-Executive Director Nov 2021
    No profile reported in Annual Report.
    Brett A. Sandercock Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 Shareholder 0 0.00%

    Profile

    since

    Note